These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1008 related items for PubMed ID: 29452208

  • 1. Outcome of ABO-incompatible adult living-donor liver transplantation for patients with hepatocellular carcinoma.
    Yoon YI, Song GW, Lee SG, Hwang S, Kim KH, Kim SH, Kang WH, Cho HD, Jwa EK, Kwon JH, Tak EY, Kirchner VA.
    J Hepatol; 2018 Jun; 68(6):1153-1162. PubMed ID: 29452208
    [Abstract] [Full Text] [Related]

  • 2. Impact of ABO-incompatibility on hepatocellular carcinoma recurrence after living donor liver transplantation.
    Kim SH, Lee EC, Na BG, Park SJ.
    Eur J Surg Oncol; 2019 Feb; 45(2):180-186. PubMed ID: 30243467
    [Abstract] [Full Text] [Related]

  • 3. ABO-incompatible Living Donor Liver Transplantation With Rituximab and Total Plasma Exchange Does Not Increase Hepatocellular Carcinoma Recurrence.
    Kim JM, Kwon CHD, Joh JW, Han S, Yoo J, Kim K, Sinn DH, Choi GS, Gerber DA, Egawa H, Lee SK.
    Transplantation; 2018 Oct; 102(10):1695-1701. PubMed ID: 29494419
    [Abstract] [Full Text] [Related]

  • 4. Long-term recurrence-free survival after liver transplantation from an ABO-incompatible living donor for treatment of hepatocellular carcinoma exceeding Milano criteria in a patient with hepatitis B virus cirrhosis: a case report.
    Nakamura Y, Hama K, Iwamoto H, Yokoyama T, Kihara Y, Konno O, Jojima Y, Shimazu M.
    Transplant Proc; 2012 Mar; 44(2):565-9. PubMed ID: 22410070
    [Abstract] [Full Text] [Related]

  • 5. ABO-incompatible living donor liver transplantation without graft local infusion and splenectomy.
    Lee SD, Kim SH, Kong SY, Kim YK, Lee SA, Park SJ.
    HPB (Oxford); 2014 Sep; 16(9):807-13. PubMed ID: 24467804
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Clinical outcome in patients with hepatocellular carcinoma after living-donor liver transplantation.
    Choi HJ, Kim DG, Na GH, Han JH, Hong TH, You YK.
    World J Gastroenterol; 2013 Aug 07; 19(29):4737-44. PubMed ID: 23922471
    [Abstract] [Full Text] [Related]

  • 8. Case-matched comparison of ABO-incompatible and ABO-compatible living donor liver transplantation.
    Kim JM, Kwon CH, Joh JW, Han SB, Sinn DH, Choi GS, Kang ES, Lee JH, Kim GS, Lee SK.
    Br J Surg; 2016 Feb 07; 103(3):276-83. PubMed ID: 26695115
    [Abstract] [Full Text] [Related]

  • 9. A simplified protocol using rituximab and immunoglobulin for ABO-incompatible low-titre living donor liver transplantation.
    Kim SH, Lee EC, Shim JR, Park SJ.
    Liver Int; 2018 May 07; 38(5):932-939. PubMed ID: 29053910
    [Abstract] [Full Text] [Related]

  • 10. Effects of loco regional treatments before living donor liver transplantation on overall survival and recurrence-free survival in South Korean patients with hepatocellular carcinoma.
    Na GH, Kim EY, Hong TH, You YK, Kim DG.
    HPB (Oxford); 2016 Jan 07; 18(1):98-106. PubMed ID: 26776857
    [Abstract] [Full Text] [Related]

  • 11. Exchange living donor liver transplantation to overcome ABO incompatibility in adult patients.
    Hwang S, Lee SG, Moon DB, Song GW, Ahn CS, Kim KH, Ha TY, Jung DH, Kim KW, Choi NK, Park GC, Yu YD, Choi YI, Park PJ, Ha HS.
    Liver Transpl; 2010 Apr 07; 16(4):482-90. PubMed ID: 20222052
    [Abstract] [Full Text] [Related]

  • 12. Kinetics of B, T, NK lymphocytes and isoagglutinin titers in ABO incompatible living donor liver transplantation using rituximab and basiliximab.
    Lee SD, Kim SH, Kong SY, Kim YK, Park SJ.
    Transpl Immunol; 2015 Jan 07; 32(1):29-34. PubMed ID: 25449537
    [Abstract] [Full Text] [Related]

  • 13. Comparative study of living and deceased donor liver transplantation as a treatment for hepatocellular carcinoma.
    Ninomiya M, Shirabe K, Facciuto ME, Schwartz ME, Florman SS, Yoshizumi T, Harimoto N, Ikegami T, Uchiyama H, Maehara Y.
    J Am Coll Surg; 2015 Mar 07; 220(3):297-304.e3. PubMed ID: 25617912
    [Abstract] [Full Text] [Related]

  • 14. High-dose hepatitis B immunoglobulin therapy in hepatocellular carcinoma with hepatitis B virus-DNA/hepatitis B e antigen-positive patients after living donor liver transplantation.
    Lee EC, Kim SH, Lee SD, Park H, Lee SA, Park SJ.
    World J Gastroenterol; 2016 Apr 14; 22(14):3803-12. PubMed ID: 27076765
    [Abstract] [Full Text] [Related]

  • 15. Section 5. Further expanding the criteria for HCC in living donor liver transplantation: when not to transplant: SNUH experience.
    Lee KW, Yi NJ, Suh KS.
    Transplantation; 2014 Apr 27; 97 Suppl 8():S20-3. PubMed ID: 24849825
    [Abstract] [Full Text] [Related]

  • 16. ABO-incompatible adult living donor liver transplantation for hepatocellular carcinoma.
    Matsuno N, Iwamoto H, Nakamura Y, Hama K, Kihara Y, Konno O, Jojima Y, Akashi I, Mijiti A, Ashizawa T, Nagao T.
    Transplant Proc; 2008 Oct 27; 40(8):2497-500. PubMed ID: 18929778
    [Abstract] [Full Text] [Related]

  • 17. Long-Term Survival Outcome Between Living Donor and Deceased Donor Liver Transplant for Hepatocellular Carcinoma: Intention-to-Treat and Propensity Score Matching Analyses.
    Wong TCL, Ng KKC, Fung JYY, Chan AAC, Cheung TT, Chok KSH, Dai JWC, Lo CM.
    Ann Surg Oncol; 2019 May 27; 26(5):1454-1462. PubMed ID: 30737669
    [Abstract] [Full Text] [Related]

  • 18. Living-donor liver transplantation associated with higher incidence of hepatocellular carcinoma recurrence than deceased-donor liver transplantation.
    Park MS, Lee KW, Suh SW, You T, Choi Y, Kim H, Hong G, Yi NJ, Kwon CH, Joh JW, Lee SK, Suh KS.
    Transplantation; 2014 Jan 15; 97(1):71-7. PubMed ID: 24056623
    [Abstract] [Full Text] [Related]

  • 19. Living donor liver transplantation versus deceased donor liver transplantation for hepatocellular carcinoma: comparable survival and recurrence.
    Sandhu L, Sandroussi C, Guba M, Selzner M, Ghanekar A, Cattral MS, McGilvray ID, Levy G, Greig PD, Renner EL, Grant DR.
    Liver Transpl; 2012 Mar 15; 18(3):315-22. PubMed ID: 22140013
    [Abstract] [Full Text] [Related]

  • 20. Comparison of acute kidney injury between ABO-compatible and ABO-incompatible living donor liver transplantation: A propensity matching analysis.
    Jun IG, Lee B, Kim SO, Shin WJ, Bang JY, Song JG, Song GW, Lee SG, Hwang GS.
    Liver Transpl; 2016 Dec 15; 22(12):1656-1665. PubMed ID: 27595780
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 51.